ArticleImaging neuroscience (Cambridge, Mass.)2025
Denoising strategies of functional connectivity MRI data in lesional and non-lesional brain diseases.
Article in Imaging neuroscience (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Brain dysconnectivity patterns associated with chronic back pain development.Brain informatics · 2026Article
- The Impact of Denoising Approaches on the Relationship Between Alzheimer's Disease Diagnostic Status and Network Topology Measures.Human brain mapping · 2026Article
- Salience network segregation and symptom profiles in psychosis risk subgroups among youth and early adults.Schizophrenia (Heidelberg, Germany) · 2025Article
- Quantification of brain functional connectivity deviations in individuals: A scoping review of functional MRI studies.NeuroImage. Clinical · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Functional connectivity magnetic resonance imaging (fcMRI) is a widely utilized tool for analyzing functional connectivity (FC) in both healthy and diseased brains. However, patients with brain disorders are particularly susceptible to head movement during scanning, which can introduce substantial noise and compromise data quality. Therefore, identifying optimal denoising strategies is essential to ensure reliable and accurate downstream data analysis for both lesional and non-lesional brain conditions. In this study, we analyzed data from four cohorts: healthy subjects, patients with brain lesions (glioma, meningioma), and patients with a non-lesional encephalopathic condition. Our goal was to evaluate various denoising strategies using quality control (QC) metrics to identify the most effective approach for minimizing noise while preserving the integrity of the blood oxygen level-dependent (BOLD) signal, tailored to each disease type. The effectiveness of denoising strategies varied based on the data quality and whether the data were derived from lesional or non-lesional diseases. At comparable levels of head motion, combinations involving independent component analysis-based automatic removal of motion artifacts (ICA-AROMA) denoising strategies were most effective for data from a non-lesional encephalopathic condition, while combinations including anatomical component correction (CC) yielded the best results for data from lesional conditions. Here, we present the first comparison of denoising pipelines for patients with lesional and non-lesional brain diseases. A key finding was that, at comparable levels of head motion, the optimal denoising strategy varies depending on the nature of the brain disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.